Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: Studies on Parkinson's and Incidental Lewy Body Disease

Biochemical and Biophysical Research Communications

Volumn 240, Issue 1, 1997, Pages 84-87

  Marshall, Karyn Ann ^a   Daniel, Susan E ^b   Cairns, Nigel ^a   Jenner, Peter ^a   Halliwell, Barry ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bcl 2; Incidental Lewy Body Disease; Oxidative stress; Parkinson's disease

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BASAL GANGLION; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LEWY BODY; NERVE DEGENERATION; NORMAL HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031558778     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7604     Document Type: Article

References (30)

1. Olanow C. W. Neurodegeneration and Neuroprotecton in Parkinson's Disease. 1996;Academic Press, San Diego.
2. Gotz M. E., Kunig G., Riederer P., Youdim M. B. Pharmac. Ther. 63:1994;37-122.
3. Fahn S., Cohen G. Ann. Neurol. 36:1992;804-812.
4. Spencer J. P., Jenner A., Butler J., Aruoma O. I., Dexter D. T., Jenner P., Halliwell B. Free Radic. Res. 24:1996;95-105.
5. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P., Halliwell B. J. Neurochem. 69:1997;1196-1203.
6. Sanchez-Ramos J. R., Overvik E., Ames B. N. Neurodegeneration. 3:1994;197-204.
7. Kerr J. F. R., Wyllie A. H., Currie A. R. Br. J. Cancer. 26:1972;239-257.
8. Anglade P., Vyas S., Javoy Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C., Agid Y. Histol. Histopathol. 12:1997;25-31.
9. Mochizuki H., Goto K., Mori H., Mizuno Y. J. Neurol. Sci. 137:1996;120-123.
10. Kosel S., Egensperger R., von Eitzen U., Mehraein P., Graeber M. B. Acta. Neuropath. 93:1997;105.
11. Walkinshaw G., Waters C. M. Neuroscience. 63:1994;975-987.
12. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., Barzilai A. Neurosci. Lett. 170:1994;136-140.
13. Masserano J. M., Gong L., Kulaga H., Baker I., Wyatt R. J. Mol. Pharmacol. 50:1996;1309-1315.
14. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. Nat. Genet. 9:1995;21-30.
15. Macaya A., Munell F., Gubits R. M., Burke R. E. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8117-8121.
16. Kubo T., Enokido Y., Yamada M., Oka T., Uchiyama Y., Hatanaka H. Brain Res. 733:1996;175-183.
17. Hengartner M. O., Horvitz H. R. Cell. 76:1994;665-676.
18. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Cell. 75:1993;241-251.
19. Reed J. C. Nature. 387:1997;773-776.
20. Schendel S. L., Xie Z., Montal M. O., Matsuyama S., Montal M., Reed J. C. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5113-5118.
21. Skulachev V. P. FEBS Lett. 397:1996;7-10.
22. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Science. 275:1997;1129-1132.
23. Zhong L. T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., Bredesen D. E. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4533-4537.
24. Mogi M., Harada M., Kondo T., Mizuno Y., Narabayashi H., Riederer P., Nagatsu T. Neurosci. Lett. 215:1996;137-139.
25. Vyas S., Javoy Agid F., Herrero M. T., Strada O., Boissiere F., Hibner U., Agid Y. J. Neurochem. 69:1997;223-231.
26. Gibb W. R. G., Lees A. J. J. Neurol. Neurosurg. Psychiatry. 51:1988;745-752.
27. Forno L. S. J. Am. Geriatr. Soc. 17:1969;557-575.
28. Bredesen D. E. Ann. Neurol. 38:1995;839-851.
29. Orrenius S., Nobel C. S., van den Dobbelsteen D. J., Burkitt M. J., Slater A. F. Biochem. Soc. Trans. 24:1996;1032-1038.
30. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy Agid F., Jenner P., Marsden C. D. Ann. Neurol. 36:1994;348-355.